Nymox Pharmaceutical Net Debt Growth & History (NYMXF)

Nymox Pharmaceutical's net debt was −$74,000 for fiscal 2024.

View full Nymox Pharmaceutical company overview

Nymox Pharmaceutical annual net debt history

Nymox Pharmaceutical annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20242024-12-31−$74,000−$4,000
20232023-12-31−$70,000$1.3M
20222022-12-31−$1.4M−$964,459
20212021-12-31−$438,541$2.7M
20202020-12-31−$3.2M$1.8M
20192019-12-31−$4.9M$2.6M
20182018-12-31−$7.5M

Nymox Pharmaceutical net debt trends

Over the last five fiscal years, Nymox Pharmaceutical's net debt increased from −$4.9M to −$74,000, a change of $4.9M. The latest reported quarter, Q4 2024, shows −$74,000.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Nymox Pharmaceutical source filings ↗

Community posts

It’s quiet here.

No posts about NYMXF yet. Start the conversation.

Write the first post